Research News and Research

RSS

Researchers trigger natural defense mechanism to alleviate intestinal inflammation

Treating inflammatory diseases of the bowel is extremely challenging: Genes, gut microbes and disrupted immune function all contribute.

31 May 2018

Agendia and Angsana partner to market MammaPrint, BluePrint breast cancer tests in Southeast Asia

Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, and Angsana Molecular & Diagnostics Laboratory Pte Ltd, a subsidiary of Parkway Pantai, announce a partnership to market the MammaPrint Breast Cancer Risk of Recurrence test and the BluePrint Molecular Subtyping test to physicians across Southeast Asia, including Singapore, Malaysia, Vietnam, Brunei and Myanmar.

31 May 2018

RaySearch signs research collaboration agreement with NIRS/QST for advancement of ion beam therapy

RaySearch has signed a research collaboration and licensing agreement with the National Institutes for Quantum and Radiological Science and Technology, a pioneer of ion beam technology based in Chiba, Japan. QST was established in 2016 when the National Institute of Radiological Sciences was merged with certain functions of the Japan Atomic Energy Agency.

31 May 2018

Cloud Pharmaceuticals enters into drug discovery collaboration with GSK

Cloud Pharmaceuticals, Inc., an Artificial Intelligence-driven drug design and development company, announced today they have entered into drug discovery collaboration with GlaxoSmithKline (GSK). Cloud will design novel small-molecule agents to GSK specified targets.

31 May 2018

Another cause of doctor burnout: Being forced to give immigrants unequal care

One patient’s death changed the course of Dr. Lilia Cervantes’ career. The patient, Cervantes said, was a woman from Mexico with kidney failure who repeatedly visited the emergency room for more than three years. In that time, her heart had stopped more than once, and her ribs were fractured from CPR.

31 May 2018

Prostate cancer survivors at higher risk of developing chronic diseases, study shows

Prostate cancer survivors taking androgen deprivation therapy (ADT), a treatment commonly used to block the release of male hormones, are at a higher risk of developing chronic diseases, according to new research published this week.

31 May 2018

MILabs' new VECTor5PET/SPECT/OI/CT system installed at TUM campus in Garching

A MILabs VECTor5PET/SPECT/OI/CT system has been installed at the Chair of Pharmaceutical Radiochemistry on the TUM Campus in Garching. Under the direction of Prof. Hans-Jurgen Wester, this institute has established a broad and internationally renowned radiopharmaceutical research program, consisting of fundamental tracer development, innovative radiolabeling strategies, and the preclinical and clinical assessment of new tracers.

31 May 2018

Mesoblast and Cartherics form partnership to develop 'off-the-shelf' CAR-T therapies for solid cancers

Mesoblast Limited today announced that it has entered into a partnership with Cartherics Pty Ltd to develop allogeneic ‘off-the-shelf’ CAR-T cells armed with multiple targeting receptors for use in solid cancers. Off the shelf CAR-T therapies have the potential to reduce costs dramatically and open up this very effective treatment to millions of cancer patients across the world.

31 May 2018

UTSA scientists explore stuttering and develop new technology to optimize brain function

A team of researchers at The University of Texas at San Antonio received a two-year, $387,000 grant, from the National Institutes of Health (NIH), to develop technology that will identify brain activity patterns that contribute to stuttering and use that technology to train people how to optimize brain functions.

31 May 2018

Telemedicine approach improves genetic counseling at community-based cancer care

Genetic counseling for cancer patients has become standard of care at academic medical centers, but patients cared for at community-based medical practices across the United States may not have access to these resources. Video and phone sessions can close that gap and bring genetic counseling to patients who would not otherwise have the chance to receive it, according to a new study from the Basser Center for BRCA at the University of Pennsylvania's Abramson Cancer Center.

31 May 2018

NIH study unravels how tularemia bacteria trick host cells to cause disease

Scientists from the National Institute of Allergy and Infectious Diseases--part of the National Institutes of Health--have unraveled the process by which the bacteria cause disease.

31 May 2018

Researchers identify workplace dress codes as hindrance for people with disabilities

According to the U.S. Census, nearly 20 million people of working age live with a disability. While past research has indicated that people living with disabilities face barriers in workplace participation, researchers from the University of Missouri have now found one hindrance to workplace participation for people with disabilities is the lack of appropriate clothing. This barrier increases their stigma and decreases their confidence.

31 May 2018

Scientists identify 'hidden' driver that helps prime the anti-tumor immune response

Like exposing a crime boss whose authority has gone undetected, St. Jude Children's Research Hospital scientists have identified a hidden driver that influences production of the T cells that fight cancer and infections. The study appears today as an advance online publication in the journal Nature.

31 May 2018

New guideline for HER2 testing in breast cancer benefits patients and clinicians

Published today, a Focused Update to the American Society of Clinical Oncology/College of American Pathologists guideline for human epidermal growth factor receptor 2 (HER2) testing in breast cancer brings new levels of clarity that will benefit patients and clinical teams alike.

31 May 2018

FDA approves first oral medication for adults with moderately to severely active ulcerative colitis

The U.S. Food and Drug Administration today expanded the approval of Xeljanz (tofacitinib) to include adults with moderately to severely active ulcerative colitis. Xeljanz is the first oral medication approved for chronic use in this indication.

30 May 2018

Novel surgical approach to limb amputation improves sensation, control of prosthesis

Humans can accurately sense the position, speed and torque of their limbs, even with their eyes shut. This sense, known as proprioception, allows humans to precisely control their body movements.

30 May 2018

Scientists engineer bi-specific antibodies that attract immune killers directly to cancer cells

Our immune system's arsenal of defenses usually protects us from cancer. But sometimes, cancer cells overwhelm or evade this elaborate defense system.

30 May 2018

Impaired maternal-fetal environment associated with lower survival after surgery in newborns with CHD

Children who undergo surgery for congenital heart disease have lower survival rates by three years of age if there are specific problems during fetal development, such as hypertension in the mother or the newborn being born preterm or small for gestational age.

30 May 2018

FDA-approved drug for lymphoma and leukemia may help treat common type of brain tumor

New Cleveland Clinic research shows for the first time that ibrutinib, an FDA-approved drug for lymphoma and leukemia, may also help treat the most common – and deadliest – type of brain tumor.

30 May 2018

Zinc and copper metabolism in baby teeth may help predict ASD risk

Using evidence found in baby teeth, researchers from the Department of Environmental Medicine and Public Health at the Icahn School of Medicine at Mount Sinai report that cycles involved in zinc and copper metabolism are dysregulated in autism spectrum disorder, and can be used to predict who will later develop the disease.

30 May 2018

Research News and Research

Researchers trigger natural defense mechanism to alleviate intestinal inflammation

Agendia and Angsana partner to market MammaPrint, BluePrint breast cancer tests in Southeast Asia

RaySearch signs research collaboration agreement with NIRS/QST for advancement of ion beam therapy

Cloud Pharmaceuticals enters into drug discovery collaboration with GSK

Another cause of doctor burnout: Being forced to give immigrants unequal care

Prostate cancer survivors at higher risk of developing chronic diseases, study shows

MILabs' new VECTor5PET/SPECT/OI/CT system installed at TUM campus in Garching

Mesoblast and Cartherics form partnership to develop 'off-the-shelf' CAR-T therapies for solid cancers

UTSA scientists explore stuttering and develop new technology to optimize brain function

Telemedicine approach improves genetic counseling at community-based cancer care

NIH study unravels how tularemia bacteria trick host cells to cause disease

Researchers identify workplace dress codes as hindrance for people with disabilities

Scientists identify 'hidden' driver that helps prime the anti-tumor immune response

New guideline for HER2 testing in breast cancer benefits patients and clinicians

FDA approves first oral medication for adults with moderately to severely active ulcerative colitis

Novel surgical approach to limb amputation improves sensation, control of prosthesis

Scientists engineer bi-specific antibodies that attract immune killers directly to cancer cells

Impaired maternal-fetal environment associated with lower survival after surgery in newborns with CHD

FDA-approved drug for lymphoma and leukemia may help treat common type of brain tumor

Zinc and copper metabolism in baby teeth may help predict ASD risk

A guide to advancing biotherapeutic research eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery